INICIO
Artículos de BITS #05
- A mapping review of take-home naloxone for people released from correctional settings. Horton, M. et al. International Journal of Drug Policy, Volume 46, 7 – 16
- A randomized controlled trial of brief interventions to reduce drug use among adults in a low-income urban emergency department: the HealthiER You study. Blow, F. C., Walton, M. A., Bohnert, A. S. et al. Addiction, Volume 112, Issue 8, Pages: 1395-1405
- Acryloylfentanyl, a recently emerged new psychoactive substance: a comprehensive review. Ujváry, I., Jorge, R., Christie, R. et al. Forensic Toxicol (2017) 35: 232
- Analytical characterization of three cathinone derivatives, 4-MPD, 4 F-PHP and bk-EPDP, purchased as bulk powder from online vendors. Apirakkan, O., Frinculescu, A., Shine, T., Parkin, M. C., Cilibrizzi, A., Frascione, N., and Abbate, V. (2017) Drug Test. Analysis Volume10, Issue2 February 2018 Pages 372-378
- Brephedrone: A new psychoactive substance seized in Brazil. Machado, Y. et al. Forensic Science International, Volume 275, June 2017, Pages 302–307
- Buprenorphine Use in Pregnant Opioid Users: A Critical Review. Soyka, M. CNS Drugs, August 2013, Volume 27, Issue 8, pp 653–662
- Causes of death up to 10 years after admissions to hospitals for self-inflicted, drug-related or alcohol-related, or violent injury during adolescence: a retrospective, nationwide, cohort study. Herbert, A. et al. The Lancet, Published: 25 May 2017
- Crack Cocaine Use in Adolescents: Clinical Characteristics and Predictors of Early Initiation. Pianca, Thiago G. et al. J Clin Psychiatry 2016;77(10):e1205–e1210
- Decline in new psychoactive substance use disorders following legislation targeting headshops: Evidence from national addiction treatment data. Smyth, B.P. and Lyons, S. and Cullen, W. Drug Alcohol Rev. 2017 Sep;36(5):609-617. doi: 10.1111/dar.12527. Epub 2017 Apr 16.
- Drug Use and Multiple Sex Partners among Homeless Ex-Offenders: Secondary Findings from an Experimental Study. Nyamathi, A.M. et al. Nurs Res. 2016 May-Jun; 65(3): 179–190
- Economic consequences of legal and illegal drugs: The case of social costs in Belgium. Lievens, D. et al. International Journal of Drug Policy , Volume 44 , 50 - 57
- Estimating the number of people who inject drugs: a proposal to provide figures nationwide and its application to France. Janssen, E. J Public Health (Oxf) 1-9. Published: 25 May 2017
- Gender differences in discharge dispositions of emergency department visits involving drug misuse and abuse—2004-2011. Manuel J.I. and Lee J. Substance Abuse Treatment, Prevention, and Policy 2017 12:28
- Gender-specific predictors of at-risk adolescents’ hazardous alcohol use—a cohort study. Jalling C. et al. Substance Abuse Treatment, Prevention, and Policy 2017 12:23
-
How does the use of multiple needles/syringes per injecting episode impact on the measurement of individual level needle and syringe program coverage?.
O’Keefe, D. et al. International Journal of Drug Policy, Volume 46, 99 – 106
- How preferences for volume-based promotions differ between at-risk and non-problem female drinkers. Trawley S.L. et al. International Journal of Drug Policy, Volume 45, July 2017, Pages 42–45
- Illicit Drug Use and Its Association with Key Sexual Risk Behaviours and Outcomes: Findings from Britain’s Third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Paquette, R., Tanton, C., et al. PLoS ONE, 12(5), e0177922
- Increased in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis. Lamy, F.R. et al. International Journal of Drug Policy, Volume 44, 121 – 129
- Longitudinal relationships of sleep and inhibitory control deficits to early adolescent cigarette and alcohol use. Warren C.M., Riggs N.R., Pentz M.A.J Adolesc. 2017 Jun;57:31-41
- Medical Marijuana Laws and Cannabis Use Intersections of Health and Policy. Compton W.M., Volkow N.D., Lopez M.F. JAMA Psychiatry. 2017;74(6):559-560
- Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study. Wiessing, L. et al. Harm Reduction Journal 2017 14:19
- Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. Sordo, L. et al. BMJ 2017;357:j1550
- New Developments in Managing Opioid Addiction: Impact of a Subdermal Buprenorphine Implant. Itzoe, ML. and Guarnieri, M. Drug Design, Development and Therapy 11 (2017): 1429–1437. PMC. Web. 8 June 2017
- Niveles de ingreso y prevalencia de tabaquismo en América Latina: revisión sistemática y meta análisis. Bardach A., García Perdomo H.A., Ruano Gándara R.A., Ciapponi A. Rev Panam Salud Publica. 2016;40(4):263–71
- Online test purchased new psychoactive substances in 5 different European countries: A snapshot study of chemical composition and price. Brunt, T.M. et al. International Journal of Drug Policy, Volume 44, 105 - 114
- Purity and adulteration in cocaine seizures and drug market inspection in Galicia (Spain) across an eight-year period. Villar Núñez, M. Á., Sánchez Morcillo, J., and Ruíz Martínez M. A. Drug Test. Analysis (2017) May 23
-
Stages of Change Model has Limited Value in Explaining the Change in Use of Cannabis among Adolescent Participants in an Efficacious Motivational Interviewing Intervention.
Dupont H.B. et al. J Psychoactive Drugs. 2017 Nov-Dec;49(5):363-372
- Teaching Neonatal Abstinence Syndrome Using Simulation. Labant, A.L., RNPalmer, E.A Clinical Simulation in Nursing Volume 13, Issue 6, June 2017, Pages 254–257
- The comparative effectiveness of outpatient treatment for adolescent substance abuse: A meta-analysis.. Tanner-Smith E.E., Wilson S.J., Lipsey M.W. Journal of Substance Abuse Treatment: 2013, 44, p. 145–158
- The emerging role of lawyers as addiction ‘quasi-experts’. Seear, K. International Journal of Drug Policy , Volume 44 , 183 - 191
- The relative prevalence of schizophrenia among cannabis and cocaine users attending addiction services. Libuy N., de Angel V., Ibáñez C., Murray R.M., Mundt Adrian P. Schizophrenia Research, Volume 194, Pages 13-17
- The social cost of illicit drugs use in Spain. Rivera, B. et al. International Journal of Drug Policy, Volume 44, 92 – 104
-
Trajectories of risk behaviors across adolescence and young adulthood: The role of race and ethnicity.
Yankey B.A., et al. J Addict Res Ther (2017) S11:017
- US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws 1991-1992 to 2012-2013. Hasin D.S., Sarvet A.L., Cerdá M., Keyes K.M., Stohl M., Galea S., Wall M.M. JAMA Psychiatry. 2017;74(6):579-588
- Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care. Gryczynski, J., McNeely, J., Wu, LT. et al. Journal of General Internal Medicine (2017) pp 1–7
- Who sells what? Country specific differences in substance availability on the Agora cryptomarket. Van Buskirk, J. et al. International Journal of Drug Policy, Volume 35, 16 – 23
